US 8034376
Lipid containing formulations
granted A61KA61K31/325A61K47/34
Quick answer
US patent 8034376 (Lipid containing formulations) held by Alnylam Pharmaceuticals, Inc. expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/325, A61K47/34, A61K9/1272, A61K9/1273